Antithrombin Alfa Terminated Phase 3 Trials for Disseminated Intravascular Coagulation (DIC) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01384409A Phase 3 Clinical Study of KW-3357 in Patients With DIC